January 2023 Banner

State Visit to Vietnam

MicrosoftTeams-image (5)

MicrosoftTeams-image (4)

COVID19 UPDATES

FDA UPDATES

EUA UPDATES

CC Slide banner

Slide

Slide 1

Learn More

IEC

Featured Activity || FDA Meets with ARTA

By Administrator 3 / January 31, 2024

The Food and Drug Administration (FDA) recently had a productive meeting with the Anti-Red Tape Authority (ARTA) on 26 January...

Featured Activity || FDA Meets with ARTA

Featured Activity || LAB for ALL in Ilocos Sur

By Administrator 3 / January 26, 2024

Under the leadership of Director General Dr. Samuel A. Zacate, the Food and Drug Administration (FDA) once again pledged its...

Featured Activity || LAB for ALL in Ilocos Sur

Featured Activity || Programang BBMSME inilunsad sa Ilocos Sur

By Administrator 3 / January 26, 2024

Pinangunahan ni Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate at Ilocos Sur Governor Jeremias “Jerry” Singson...

Featured Activity || Programang BBMSME inilunsad sa Ilocos Sur

Featured Activity || Post-Formal Benchmarking Exercise with the World Health Organization

By Administrator 3 / January 22, 2024

The Food and Drug Administration (FDA) with the assistance of the World Health Organization (WHO) Country Office has successfully conducted...

Featured Activity || Post-Formal Benchmarking Exercise with the World Health Organization

Featured Activity || CDRR KAPIHAN AT TALAKAYAN 2023 Q4 – VETERINARY DRUGS

By Administrator 3 / January 22, 2024

In line with the commitment of the Food and Drug Administration (FDA) to ensure the safety, efficacy, and quality of...

Featured Activity || CDRR KAPIHAN AT TALAKAYAN 2023 Q4 – VETERINARY DRUGS

Featured Activity || CDRR KAPIHAN AT TALAKAYAN 2023 Q4 – HUMAN DRUGS

By Administrator 3 / January 22, 2024

The Center for Drug Regulation and Research (CDRR) hosted a productive morning session of Kapihan at Talakayan for Human Drugs...

Featured Activity || CDRR KAPIHAN AT TALAKAYAN 2023 Q4 – HUMAN DRUGS

Featured Activity || HIGHLIGHTS: LAB FOR ALL | Lucena, Quezon

By Administrator 2 / January 15, 2024

Ang unang LAB FOR ALL para sa taong 2024 ay ginanap sa Quezon Convention Center, Lucena City noong ika-9 na...

Featured Activity || HIGHLIGHTS: LAB FOR ALL | Lucena, Quezon

Featured Activity || FDA Benchmarks International Legal and Regulatory Framework for Biocides

By Administrator 2 / January 15, 2024

FDA Benchmarks International Legal and Regulatory Framework for Biocides On 08-09 January 2024, the Center for Cosmetics and Household/Urban Hazardous...

Featured Activity || FDA Benchmarks International Legal and Regulatory Framework for Biocides. #FDA #Educate #Regulate #Monitor

By Administrator 2 / January 15, 2024

FDA Benchmarks International Legal and Regulatory Framework for Biocides. #FDA #Educate #Regulate #Monitor See more:-> https://bit.ly/41YBhAG

Featured Activity || FDA Benchmarks International Legal and Regulatory Framework for Biocides. #FDA #Educate #Regulate #Monitor

Featured Activity || Ceremonial Signing of Memorandum of Agreement between Food and Drug Administration Philippines and Calamba City Government

By Administrator 3 / January 11, 2024

Ceremonial Signing of Memorandum of Agreement between Food and Drug Administration Philippines and Calamba City Government for the FDA initiative project for Micro,...

Featured Activity || Ceremonial Signing of Memorandum of Agreement between Food and Drug Administration Philippines and Calamba City Government

Featured Event

Play

Featured Video

Play

Our Services

For Products and Establishments registration at FDA

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2024-0173 || Public Health Warning Against the Purchase and Use of Unregistered Household/Urban Pesticide (HUP) “GOLDEER GOOD QUALITY BLACK MOSQUITO REPELLENT INCENSE (JASMINE SCENT)”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unregistered household/urban pesticide (HUP) product, GOLDEER...

FDA Advisory No.2024-0172 || Public Health Warning Against the Purchase and Use of Unregistered Household/Urban Pesticide (HUP) “LION-TIGER REGULAR SIZE LAVENDER MOSQUITO KILLER SCENTED COILS”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unregistered household/urban pesticide (HUP) product, LION-TIGER...

FDA Advisory No.2024-0116 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “LA BELLA VIDA EAU DE TOILETTE FOR HER”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, LA BELLA VIDA...

FDA Advisory No.2024-0113 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “KALIYA BEAUTY SUNSCREEN SPF 65+”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, KALIYA BEAUTY SUNSCREEN...

FDA Advisory No.2024-0112 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “HIMALAYA FRESH START OIL CLEAR FACE WASH PEACH”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, HIMALAYA FRESH START...

FDA Advisory No.2024-0111 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “YS LUXESSENTIALS FLINCH INSTANT WHITENING LOTION SPF 80”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, YS LUXESSENTIALS FLINCH...

FDA Advisory No.2024-0110 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “CHIN CHUN SU FACIAL CREAM WITH BETA CAROTENE”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, CHIN CHUN SU...

FDA Advisory No.2024-0109 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “FAMXILI WATER-BASED NAIL POLISH”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, FAMXILI WATER-BASED NAIL...

FDA Advisory No.2024-0108 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “IMAN OF NOBLE”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, IMAN OF NOBLE....

FDA Advisory No.2024-0107 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic “NUILT POUR FEMME BOOS HOGO BOOS”

February 1, 2024

The Food and Drug Administration (FDA) warns the public NOT TO PURCHASE AND USE unnotified cosmetic product, NUILT POUR FEMME...

Announcement || CDRR YEAR-END PROGRAM IMPLEMENTATION REVIEW (PIR) AND PLANNING WORKSHOP FOR CALENDAR YEAR 2023

Please be informed that the Center for Drug Regulation and Research (CDRR) will be having its 2023 CDRR Year-End Program ...
Read More

December 4, 2023

Announcement || CDRRHR 2023 YEAR-END PERFORMANCE REVIEW AND STRATEGIC PLANNING FOR CY 2024

Please be informed that the Center for Device Regulation, Radiation Health, and Research (CDRRHR) will be conducting its Year-End Performance ...
Read More

December 1, 2023

Announcement || Notice of Public Consultation

In reference to the finalization of the draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges ...
Read More

November 24, 2023

FDA on the News

FDA on the News || QC gov’t at FDA sanib pwersa para palakasin ang MSMEs

April 17, 2023

Nakipagsanib puwersa ang lokal na pamahalaan ng Quezon City sa Food and Drug Administration para palakasin pa ang Micro, Small,...

FDA on the News || LGU, FDA kapit-bisig sa pagpapalago sa MSMEs sa QC

April 17, 2023

MANILA, Philippines – NAIS palawakin pa ng Quezon City Local Governmemt ang suporta para sa mga Micro Small and Medium...

FDA on the News || QC, FDA ink assistance agreement for MSMEs

April 17, 2023

The Quezon City government and the Food and Drug Administration (FDA) signed on Friday, April 14, a memorandum of agreement...

FDA on the News || QC gov’t partners with FDA to aid MSMEs

April 17, 2023

MANILA, Philippines — The Quezon City government has joined forces with the Food and Drugs Administration (FDA) to support micro,...

FDA on the News || QC, FDA ink agreement to aid MSMEs

April 17, 2023

MANILA – The Quezon City local government and the Food and Drug Administration (FDA) have agreed to work together to help...

FDA on the News || QC, FDA partner on micro business development

April 17, 2023

In a bid to help micro, small and medium enterprises (MSMEs), the Quezon City government on Friday partnered with the...

FDA on the News || Quezon City LGU at FDA, kapit-bisig sa pagpapalago ng MSMEs

April 17, 2023

MANILA, Philippines — Palalawakin pa ng Quezon City Local Government ang suporta para sa mga Micro Small and Medium Enterprises...

FDA on the News || Quezon City, FDA to help MSMEs create more jobs (MANILA TIMES)

April 17, 2023

QUEZON City Mayor Maria Josefina "Joy" Belmonte on Friday announced that the local government has joined forces with the Food...

FDA on the News || The Quezon City government yesterday partnered with the Food and Drug Administration (FDA) to provide technical assistance and training for micro, small and medium enterprises (MSMEs) in the city.

April 17, 2023

The partnership is part of the city’s Bigyang-Halaga, Bangon MSMEs (BBMSME) program, which aims to streamline registration processes and make...

FDA on the News || SMNI News: Quezon City at FDA, lumagda ng kasunduan upang tulungan ang MSMEs

April 17, 2023

Mabibigyan ng pagkakataon ang mga Micro, Small, and Medium Enterprises ng Lungsod ng Quezon na mapadali at maintindihan ang pagkakaroon...

Press Release || THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE

December 28, 2023

“THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE” In its...

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

November 25, 2023

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit, adulterated,...

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

November 25, 2023

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit,...

FDA Press Statement || FDA joins #MedSafetyWeek 2023

November 4, 2023

Play your part in medicines safety. Whether you’re a patient, doctor, nurse, or pharmacist, you can help make medicines safer...

FDA Press Statement || Press Release on the F-Pop Initiative

October 31, 2023

The Food and Drug Administration (FDA) is pleased to announce the launch of the Functional Pop Beauty “F-Pop” Initiative, a...

FDA Press Statement || FDA – DTI Price Monitoring at Inspection sa Divisoria 18 August 2023

August 18, 2023

Nakiisa ang Food and Drug Administration (FDA) sa isinagawang price monitoring and inspection ng Department of Trade and Industry (DTI)...

FDA Press Statement || Arrest of Chinese national for violation of RA 3720, RA 9711 and the Consumer Act of the Philippines

August 9, 2023

On June 26, 2023, the Food and Drug Administration North Luzon Regulatory Enforcement Unit (REU) together with the Criminal Investigation...

FDA Press Statement || Approval of Zuranolone (Zurzuvae™), first oral treatment for postpartum depression (PPD)

August 9, 2023

On 04 August 2023, the US Food and Drug Administration (US FDA) approved Zuranolone (Zurzuvae™), the first and only oral...

FDA Press Statement || The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion for Booster Injection (IM) for 12 years of age and older.

August 8, 2023

The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion...

FDA Press Statement || 06 JULY 2023 – The Food and Drug Administration (FDA) Launches Taskforce Moccus to Facilitate the Evaluation of African Swine Fever (ASF) Vaccine

July 12, 2023

The Food and Drug Administration (FDA) Director General Dr. Samuel Zacate Launches Taskforce Moccus, which is an Organizational Unit of...

Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

January 9, 2024

Please be informed that the CFRR has drafted the attached FDA Circular entitled “Guidelines for the Classification of Vitamins and...

Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

December 22, 2023

All concerned stakeholders may submit comments in MS word format via email to [email protected]. The deadline for submission of comment...

Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

Draft for Comments || Amendment to FDA Circular No. 2022-004 entitled “Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals” to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies

December 22, 2023

All comments may be sent to [email protected]. The deadline for submission of comments is on 05 January 2024. In...

Draft for Comments || Amendment to FDA Circular No. 2022-004 entitled “Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals” to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies

Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles

December 19, 2023

The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is hereby circulating the draft of the attached...

Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles

Draft for Comments || Submission of Position Paper/Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs” and its Amendments

December 13, 2023

This refers to the public consultation on the FDA's new schedule of Fees and Charges conducted virtually on 27 October...

Draft for Comments || Submission of Position Paper/Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs” and its Amendments

Draft for Comments || Further Regulatory Flexibilities for the Implementation of FDA Circular No. 2020-025 “Implementing Guidelines for DOH Administrative Order No. 2019-0019″

November 30, 2023

The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is circulating the draft on the proposed FDA...

Draft for Comments || Further Regulatory Flexibilities for the Implementation of FDA Circular No. 2020-025 “Implementing Guidelines for DOH Administrative Order No. 2019-0019″

Draft for Comments || Guidelines on the Filing and Submission of Applications for the Licensing of Cosmetic Establishments through the Food and Drug Administration (FDA) eServices Portal System

November 30, 2023

The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is soliciting comments on the proposed FDA Circular,...

Draft for Comments || Guidelines on the Filing and Submission of Applications for the Licensing of Cosmetic Establishments through the Food and Drug Administration (FDA) eServices Portal System

Draft for Comments || Updates and Amendments to the List of Banned and Restricted Pesticides and Ingredients in Household/Urban Pesticides

November 28, 2023

The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is soliciting comments on the proposed policy, provisionally...

Draft for Comments || Updates and Amendments to the List of Banned and Restricted Pesticides and Ingredients in Household/Urban Pesticides

Draft for Comments || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)

November 24, 2023

All comments may be sent to [email protected]. The deadline for submission of comments is on 08 December 2023. I. RATIONALE...

Draft for Comments || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)

Draft for Comments || Adoption of the Philippine National Standards (PNS) and its Recommended Code of Practices (RCP) for Processed Food Products as Technical Regulation

November 20, 2023

All concerned stakeholders may submit comments in MSWord format via email to [email protected] on or before 05 December 2023 using...

Draft for Comments || Adoption of the Philippine National Standards (PNS) and its Recommended Code of Practices (RCP) for Processed Food Products as Technical Regulation

Bids and Awards

NP-SVP(A)-2023-0321-SLC || Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)

December 27, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)

NP-SVP(A)-2023-0321-SLC || Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)

ITB No. 2023-0323-AFS-EPA || Procurement of Security Services for the food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL at Fabella Hospital, DOH-Manila) for CY 2024

December 27, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Security Services for the food and Drug Administration (FDA) - Central Office,...

ITB No. 2023-0323-AFS-EPA || Procurement of Security Services for the food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL at Fabella Hospital, DOH-Manila) for CY 2024

ITB No. 2023-0322-AFS-EPA || Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City for CY 2024

December 27, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) –...

ITB No. 2023-0322-AFS-EPA || Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City for CY 2024

ITB No.2023-0314-DTQAL_EPA || Procurement of Janitorial Services for Davao Testing Quality Assurance Laboratory (DTQAL) Located at Tagum City for 12 Months

December 20, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Janitorial Services for Davao Testing Quality Assurance Laboratory (DTQAL) Located at Tagum...

ITB No.2023-0314-DTQAL_EPA || Procurement of Janitorial Services for Davao Testing Quality Assurance Laboratory (DTQAL) Located at Tagum City for 12 Months

ITB No.2023-0313-CSL_EPA || Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of CSL (ATQAL, CTQAL, DTQAL, and PLSD)

December 20, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of CSL (ATQAL, CTQAL, DTQAL,...

ITB No.2023-0313-CSL_EPA || Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of CSL (ATQAL, CTQAL, DTQAL, and PLSD)

NP-SVP(A)-2023-0312-RFO-MEC || Procurement for Meals For Mindanao East Cluster Operational Planning and Sportsfest at Region XI on 19-20 December 2023

December 14, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for Meals For Mindanao East Cluster Operational Planning and Sportsfest at Region XI...

NP-SVP(A)-2023-0312-RFO-MEC || Procurement for Meals For Mindanao East Cluster Operational Planning and Sportsfest at Region XI on 19-20 December 2023

NP-SVP(A)-2023-0309-NLC || Procurement of Service Provider to Conduct Geotechnical/Soil Boring Investigation for 2,000 sqm lot proposed Food and Drug Administration Regional Field Office II, 3-Storey Building with Basement Located at Carig Sur, Tuguegarao City, Cagayan

December 7, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Service Provider to Conduct Geotechnical/Soil Boring Investigation for 2,000 sqm lot proposed...

NP-SVP(A)-2023-0309-NLC || Procurement of Service Provider to Conduct Geotechnical/Soil Boring Investigation for 2,000 sqm lot proposed Food and Drug Administration Regional Field Office II, 3-Storey Building with Basement Located at Carig Sur, Tuguegarao City, Cagayan

NP-SVP(A)-2023-0299-PPS || Procurement for the Supply and Delivery of Various FDA Academy Collaterals which will be given as Tokens/Giveaways for the Resource Speakers and Promotion of the FDA Academy Training/Seminar Activities for CY 2023

December 7, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Various FDA Academy Collaterals which will be...

NP-SVP(A)-2023-0308-AFS || Procurement for the Common Office Supplies and Consumables

December 5, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Common Office Supplies and Consumables

NP-SVP(A)-2023-0308-AFS || Procurement for the Common Office Supplies and Consumables

NP-SVP(A)-2023-0307-BAC || Bus Rental for the Cascading of the BAC Revised QWPs, Templates and Other Procurement Matters to be held on 13-15 December 2023 within Batangas

December 4, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Bus Rental for the Cascading of the BAC Revised QWPs, Templates and Other Procurement...

Featured Activity

Featured Event

Featured Video

Our Services

Verification Portal

eServices Portal

ePortal System

ePortal v.2 System

RRDportal

Verification Portal

eServices Portal

ePortal System

ePortal v.2 System

RRDportal

COVID19-related Updates

Latest Advisories

Announcement

FDA on the News

Press Statements

Draft for Comments

Bids and Awards

Latest Issuances

Quick Menus

Recent Posts

Quick Links

Contact Information

Address:

Email: [email protected]